Concepedia

María Antonia Egea

MA

Statistics

Publications

6

Citations

632

H-Index

6

Active since

2011

Affiliations

Universitat de Barcelona(Current)

Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona

University of Trás-os-Montes and Alto Douro

Biomedical Research Networking Center on Neurodegenerative Diseases

University of Coimbra

María Antonia Egea is an author at Universitat de Barcelona specializing in nanomedicine, pharmacology, and biomedical engineering.

Top concepts

Publications per year

2011–2018

6

Publications

6

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

Elena Sánchez‐López, Miren Ettcheto, María Antonia Egea et al. · Journal of Nanobiotechnology · 2018 · 270 citations · Full text

Memantine‐Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma

Elena Sánchez‐López, María Antonia Egea, Benjamin Davis et al. · Small · 2017 · 113 citations

New potential strategies for Alzheimer's disease prevention: pegylated biodegradable dexibuprofen nanospheres administration to APPswe/PS1dE9

Elena Sánchez‐López, Miren Ettcheto, María Antonia Egea et al. · Nanomedicine Nanotechnology Biology and Medicine · 2016 · 84 citations

, , +11

Improved and Safe Transcorneal Delivery of Flurbiprofen by NLC and NLC-Based Hydrogels

Elisabet González‐Mira, Saša Nikolić, Ana Cristina Calpena et al. · Journal of Pharmaceutical Sciences · 2011 · 70 citations

, , +9

Flurbiprofen PLGA-PEG nanospheres: Role of hydroxy-β-cyclodextrin on ex vivo human skin permeation and in vivo topical anti-inflammatory efficacy

E. Vega, María Antonia Egea, Marı́a Luisa Garduño-Ramı́rez et al. · Colloids and Surfaces B Biointerfaces · 2013 · 61 citations

, , +7

Rows per page

1–5 of 6